DE68901105D1 - Alkensaeurederivate. - Google Patents

Alkensaeurederivate.

Info

Publication number
DE68901105D1
DE68901105D1 DE8989107912T DE68901105T DE68901105D1 DE 68901105 D1 DE68901105 D1 DE 68901105D1 DE 8989107912 T DE8989107912 T DE 8989107912T DE 68901105 T DE68901105 T DE 68901105T DE 68901105 D1 DE68901105 D1 DE 68901105D1
Authority
DE
Germany
Prior art keywords
derivatives
alkensaur
new
acid derivatives
alkenoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989107912T
Other languages
German (de)
English (en)
Inventor
Ulrich Dr Rosentreter
Harold Dr Kluender
Trevor S Dr Abram
Peter Dr Norman
Stephen R Dr Tudhope
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of DE68901105D1 publication Critical patent/DE68901105D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/14—Monocyclic dicarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE8989107912T 1988-05-13 1989-05-02 Alkensaeurederivate. Expired - Lifetime DE68901105D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8811423A GB2218416A (en) 1988-05-13 1988-05-13 Leukotriene disease antagonists

Publications (1)

Publication Number Publication Date
DE68901105D1 true DE68901105D1 (de) 1992-05-07

Family

ID=10636891

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989107912T Expired - Lifetime DE68901105D1 (de) 1988-05-13 1989-05-02 Alkensaeurederivate.

Country Status (8)

Country Link
US (2) US5041638A (enrdf_load_stackoverflow)
EP (1) EP0341551B1 (enrdf_load_stackoverflow)
JP (1) JP2788055B2 (enrdf_load_stackoverflow)
AT (1) ATE74346T1 (enrdf_load_stackoverflow)
DE (1) DE68901105D1 (enrdf_load_stackoverflow)
ES (1) ES2033483T3 (enrdf_load_stackoverflow)
GB (1) GB2218416A (enrdf_load_stackoverflow)
GR (1) GR3004253T3 (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100493D0 (en) * 1991-01-10 1991-02-20 Bayer Ag Substituted alkenoic acid and its derivatives
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943634A1 (de) * 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
US6761632B2 (en) * 2000-08-31 2004-07-13 Igt Gaming device having perceived skill
DE10109861A1 (de) * 2001-03-01 2002-09-05 Bayer Ag Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate
US7597621B2 (en) * 2005-09-06 2009-10-06 Igt Gaming device having progressive awards and supplemental awards
DE102005050377A1 (de) 2005-10-21 2007-04-26 Bayer Healthcare Ag Heterocyclische Verbindungen und ihre Verwendung
DE102005050375A1 (de) 2005-10-21 2007-04-26 Bayer Healthcare Ag Tetrazol-Derivate und ihre Verwendung
DE102005050376A1 (de) 2005-10-21 2007-05-31 Bayer Healthcare Ag Dicarbonsäure-Derivate und ihre Verwendung
DE102005050497A1 (de) 2005-10-21 2007-04-26 Bayer Healthcare Ag Difluorphenol-Derivate und ihre Verwendung
DE102005050498A1 (de) 2005-10-21 2007-06-06 Bayer Healthcare Aktiengesellschaft Cyclopropylessigsäure-Derivate und ihre Verwendung
DE102007015034A1 (de) 2007-03-29 2008-10-02 Bayer Healthcare Ag Lactam-substituierte Dicarbonsäuren und ihre Verwendung
DE102007015035A1 (de) * 2007-03-29 2008-10-02 Bayer Healthcare Ag Substituierte Dibenzoesäure-Derivate und ihre Verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3266442D1 (en) * 1982-01-23 1985-10-24 Basf Ag Phenylethylene derivatives, their preparation and use as medicines
EP0218728A1 (en) * 1985-04-03 1987-04-22 Yamanouchi Pharmaceutical Co. Ltd. Phenylene derivatives
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds

Also Published As

Publication number Publication date
ATE74346T1 (de) 1992-04-15
ES2033483T3 (es) 1993-03-16
GR3004253T3 (enrdf_load_stackoverflow) 1993-03-31
US5159097A (en) 1992-10-27
JPH0215045A (ja) 1990-01-18
EP0341551B1 (en) 1992-04-01
EP0341551A1 (en) 1989-11-15
US5041638A (en) 1991-08-20
GB8811423D0 (en) 1988-06-15
GB2218416A (en) 1989-11-15
JP2788055B2 (ja) 1998-08-20

Similar Documents

Publication Publication Date Title
NO921002D0 (no) Nye estere av tienylkarboksylsyrer og aminoalkoholer, deres kvartaeriseringsprodukter, og fremstilling og anvendelseav forbindelsene
NO891523L (no) Alfa-substituerte 4-(kinolin-2-yl-metoksy)fenyl-eddiksyrerog -estere.
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
DE68901105D1 (de) Alkensaeurederivate.
FI885651A7 (fi) Menetelmä optisesti aktiivisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi sekä välituotteita
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
DE3884517D1 (de) Biologisch aktive carbonsaeureester.
NO893270D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
NO880731D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
DE3785132D1 (de) Herstellung optisch aktiver cyclopropancarbonsaeuren.
DE3674351D1 (de) Optisch aktive benzoesaeureesterderivate.
DK0610697T3 (da) Imidazolyl-substituerede phenyleddikesyreprolinamider.
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
DE3679213D1 (de) Herstellung von estern der butandikarbonsaeure.
FI891371L (fi) Menetelmä 4-halogeeni-3-okso-2-alkoksi-imino-voihappoesterien valmistamiseksi
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
DK576687D0 (da) Terapeutisk aktive alkensyrederivater
DE68918924D1 (de) Phosphorsäureester.
PT87064A (pt) Process for the preparation of 5-hydroxydiprafenone and its acid addition salts
FI892291A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 6-fenoksimetyyli-4-hydroksitetrahydropyran-2-onien ja 6-tiofenoksimetyyli-4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojohdannaisten, suolojen ja estereiden valmistamiseksi
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
NO165396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere.
DE3486091D1 (de) Herstellung von butandicarboxylsaeureestern.
DE68913040D1 (de) Herstellungsverfahren von essigsäure arylestern.
NO851195L (no) Fremgangsmaate for fremstilling av askorbinsyreestere.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER HEALTHCARE AG, 51373 LEVERKUSEN, DE

8339 Ceased/non-payment of the annual fee